Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Paul

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1)Jay A Cadieux, Zaihui Zhang, Maryanne Mattice, et al.
Royal Society Open Science|August 30, 2021
Contact transfer of engineered nanomaterials in the workplaceIrene Andreu, Tuan M Ngo, Viridiana Perez, et al.
Journal of the American Chemical Society|August 16, 2020
Atomistic Insights into the Stability of Pt Single-Atom ElectrocatalystsFlorian D Speck, Michael T Y Paul, Francisco Ruiz-Zepeda, et al.
Human Mutation|January 16, 2007
Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathiesHarald Bär, Bertrand Goudeau, Sarah Wälde, et al.
Blood Advances|June 4, 2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermediaAli Taher, Michael D Diamantidis, Antonis Kattamis, et al.
Epilepsy & Behavior : E&B|January 15, 2020
The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinicMatthew S Gentry, Zaid Afawi, Dustin D Armstrong, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitorsZaihui Zhang, Vishnumurthy Kodumuru, Serguei Sviridov, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 2023
Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety EvaluationAlison Cutts, Sultan Chowdhury, Laszlo G Ratkay, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1)Jay A Cadieux, Zaihui Zhang, Maryanne Mattice, et al.
Royal Society Open Science|August 30, 2021
Contact transfer of engineered nanomaterials in the workplaceIrene Andreu, Tuan M Ngo, Viridiana Perez, et al.
Journal of the American Chemical Society|August 16, 2020
Atomistic Insights into the Stability of Pt Single-Atom ElectrocatalystsFlorian D Speck, Michael T Y Paul, Francisco Ruiz-Zepeda, et al.
Human Mutation|January 16, 2007
Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathiesHarald Bär, Bertrand Goudeau, Sarah Wälde, et al.
Blood Advances|June 4, 2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermediaAli Taher, Michael D Diamantidis, Antonis Kattamis, et al.
Epilepsy & Behavior : E&B|January 15, 2020
The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinicMatthew S Gentry, Zaid Afawi, Dustin D Armstrong, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitorsZaihui Zhang, Vishnumurthy Kodumuru, Serguei Sviridov, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 2023
Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety EvaluationAlison Cutts, Sultan Chowdhury, Laszlo G Ratkay, et al.
Pageof 11